↳ Topics · 2 papers · 1 editorial
Mitochondrial multitaskers, AMPK signalling, and the gap between published mechanism research and the consumer-marketing narrative.
§ About this topic
Metabolic-pathway research focuses on mitochondrial-derived peptides — small signalling molecules encoded by mitochondrial DNA — and their effect on cross-tissue metabolic state. The mechanism literature is interesting and reasonably documented: AMPK activation, mitochondrial biogenesis, fat-oxidation rates, exercise-mimetic adaptations. The consumer-marketing translation (weight loss, exercise replacement) outruns the evidence; this cluster stays at the mechanism level.
↳ Editorial in this topic
A small family of peptides encoded by mitochondrial DNA, what they appear to do at the cellular level, and why the human-outcome literature is much thinner than the consumer-marketing volume suggests.
↳ Peer-reviewed papers in this topic
“Cross-sectional study of mitochondrial-derived peptide levels against metabolic biomarkers. Correlative; not causal.”
“Reviews evidence for mitochondrial-derived peptides as exercise-mimetic candidates. Mixed signals across studies; no consensus on outcome equivalence.”
↳ Related topics
↳ Topic
How short signalling peptides accelerate the body's own tissue-repair machinery — wound closure, tendon healing, gut barrier integrity, vascular regrowth.
↳ Topic
The biological-vs-chronological-age question. Telomere maintenance, senescent-cell biology, and the small family of short peptides that show up in both literatures.
↳ Topic
Short peptides that influence BDNF, neurotrophic signalling and stress-resilience pathways. The most clinically-mature area in this library.